A Remotely Delivered GLP-1RA–Supported Specialist Weight Management Program in Adults Living With Obesity: Retrospective Service Evaluation
JMIR Formative Research · 2025
DOI: 10.2196/72577 ↗Kurz gefasst
Fachartikel in der Zeitschrift JMIR Formative Research, 2025. Verfasst von Rebecca Richards und 3 weiteren Autor:innen. Beteiligte Einrichtung: Second Nature, London, United Kingdom. Hauptthemen laut MEDLINE: Obesity, Weight Reduction Programs, Glucagon-Like Peptides, Glucagon-Like Peptide-1 Receptor Agonists. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Limited access to specialist weight management services restricts the implementation of novel pharmacotherapies for obesity such as glucagon-like peptide-1 receptor agonists (GLP-1RAs) in the UK National Health Service (NHS). Second Nature, a commercial digital health company, offers a remotely delivered program combining a GLP-1RA medication (semaglutide) with digital behavioral support, potentially providing a scalable solution. However, evidence for long-term effectiveness in this real-world context is limited.
Objective
This study aimed to evaluate the 12-month effectiveness, feasibility, acceptability, and potential cost-effectiveness of the remotely delivered, semaglutide-supported weight management program by Second Nature.
Methods
This retrospective service evaluation analyzed data from participants who initiated the program between September and December 2023. The primary outcome was weight change at 12 months among participants with available data (completers). Secondary outcomes included retention, program engagement (measured by views of the Home screen in the app), behavioral changes, side effects, participant experience (qualitative analysis), and a comparative cost analysis against an NHS specialist weight management service. An “active subscription” was defined as maintaining a paid subscription for the full 12-month period. Descriptive statistics and paired 2-tailed t tests evaluated outcomes.
Results
Data from 341 participants were included at baseline (282/341, 82.7% women; mean age 49, SD 11.1 years; mean baseline BMI 37.9, SD 6.9 kg/m2). At 12 months, 39.6% (135/206) maintained an active subscription, while 60.4% (206/341) became inactive. Weight data at 12 months were available for 179 participants (52.5% of the baseline cohort; 100% of active and 19.4% of inactive participants). Among completers who maintained an active subscription, the mean weight loss was 20.0 kg (SD 8.7 kg; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Second Nature, London, United Kingdom.
- Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
ORCID-Profile: Rebecca Richards, Michael Whitman, Gina Wren, Peta Campion
Zitieren
APA
Richards, R., Whitman, M., Wren, G., & Campion, P. (2025). A Remotely Delivered GLP-1RA–Supported Specialist Weight Management Program in Adults Living With Obesity: Retrospective Service Evaluation. JMIR Formative Research. https://doi.org/10.2196/72577
Vancouver
Richards R, Whitman M, Wren G, Campion P. A Remotely Delivered GLP-1RA–Supported Specialist Weight Management Program in Adults Living With Obesity: Retrospective Service Evaluation. JMIR Formative Research. 2025. doi:10.2196/72577
BibTeX
@article{Richards2025,
author = {Richards, Rebecca and Whitman, Michael and Wren, Gina and Campion, Peta},
title = {A Remotely Delivered GLP-1RA–Supported Specialist Weight Management Program in Adults Living With Obesity: Retrospective Service Evaluation},
journal = {JMIR Formative Research},
year = {2025},
doi = {10.2196/72577}
}
EUVIMED